Tuis2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Vorige sluiting
$14,80
Dagwisseling
$14,70 - $15,10
Jaarwisseling
$11,52 - $19,50
Markkapitalisasie
62,83 mjd HKD
Gemiddelde volume
5,35 m
P/V-verhouding
20,32
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 10,16 mjd | -5,09% |
Bedryfskoste | 4,25 mjd | -14,46% |
Netto inkomste | 759,24 m | 635,70% |
Netto winsgrens | 7,48 | 679,17% |
Wins per aandeel | — | — |
EBITDA | 1,00 mjd | 115,25% |
Effektiewe belastingkoers | 9,46% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 16,12 mjd | 3,45% |
Totale bates | 117,46 mjd | 3,52% |
Totale aanspreeklikheid | 57,53 mjd | 1,18% |
Totale ekwiteit | 59,93 mjd | — |
Uitstaande aandele | 2,66 mjd | — |
Prys om te bespreek | 0,83 | — |
Opbrengs op bates | 0,79% | — |
Opbrengs op kapitaal | 0,96% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 759,24 m | 635,70% |
Kontant van bedrywe | 1,49 mjd | 56,45% |
Kontant van beleggings | -1,17 mjd | -119,37% |
Kontant van finansiering | -500,30 m | 46,76% |
Netto kontantverandering | -85,94 m | 85,18% |
Beskikbare kontantvloei | 2,92 mjd | 9,19% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
40 557
